Literature DB >> 27863047

Theoretical studies on the selective mechanisms of GSK3β and CDK2 by molecular dynamics simulations and free energy calculations.

Sufang Zhao1, Jingyu Zhu2, Lei Xu3, Jian Jin2.   

Abstract

Glycogen synthase kinase 3 (GSK3) is a serine/threonine protein kinase which is widely involved in cell signaling and controls a broad number of cellular functions. GSK3 contains α and β isoforms, and GSK3β has received more attention and becomes an attractive drug target for the treatment of several diseases. The binding pocket of cyclin-dependent kinase 2 (CDK2) shares high sequence identity to that of GSK3β, and therefore, the design of highly selective inhibitors toward GSK3β remains a big challenge. In this study, a computational strategy, which combines molecular docking, molecular dynamics simulations, free energy calculations, and umbrella sampling simulations, was employed to explore the binding mechanisms of two selective inhibitors to GSK3β and CDK2. The simulation results highlighted the key residues critical for GSK3β selectivity. It was observed that although GSK3β and CDK2 share the conserved ATP-binding pockets, some different residues have significant contributions to protein selectivity. This study provides valuable information for understanding the GSK3β-selective binding mechanisms and the rational design of selective GSK3β inhibitors.
© 2016 John Wiley & Sons A/S.

Entities:  

Keywords:  Glycogen synthase kinase 3 (GSK3); cyclin-dependent kinase 2 (CDK2); free energy calculations; molecular dynamics simulations; selectivity

Mesh:

Substances:

Year:  2016        PMID: 27863047     DOI: 10.1111/cbdd.12907

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  2 in total

1.  Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms.

Authors:  Jingyu Zhu; Ke Ke; Lei Xu; Jian Jin
Journal:  RSC Adv       Date:  2019-06-28       Impact factor: 4.036

2.  Evaluation of Allicin Against Alveolar Echinococcosis In Vitro and in a Mouse Model.

Authors:  Chuanchuan Liu; Haining Fan; Lu Guan; Lan Ma; Ri-Li Ge
Journal:  Acta Parasitol       Date:  2021-06-18       Impact factor: 1.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.